Evidence map›Paper›PMID 27503068›Full record

Observational studyBMC infectious diseases2016

Prospective evaluation of SeptiFast Multiplex PCR in children with systemic inflammatory response syndrome under antibiotic treatment.

Franziska Gies, Eva Tschiedel, Ursula Felderhoff-Müser, Peter-Michael Rath, Joerg Steinmann, Christian Dohna-Schwake

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Point-of-Care Method T2BacteriaMicroorganisms · 2024
    Article
  4. Review
  5. Time to positivity of blood cultures in neonatal late-onset bacteraemia.Archives of disease in childhood. Fetal and neonatal edition · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Franziska GiesDepartment of Pediatrics I, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.
Eva TschiedelDepartment of Pediatrics I, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.
Ursula Felderhoff-MüserDepartment of Pediatrics I, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.
Peter-Michael RathInstitute of Medical Microbiology, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.
Joerg SteinmannInstitute of Medical Microbiology, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.
Christian Dohna-SchwakeDepartment of Pediatrics I, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany. christian.dohna-schwake@uk-essen.de.ORCID http://orcid.org/0000-0001-8973-5406
University of Duisburg-Essen · DEAssistance Publique – Hôpitaux de Paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntimicrobially pre-treated children with systemic inflammation often pose a diagnostic challenge to the physician. We aimed to evaluate the additional use of SeptiFast multiplex polymerase chain reaction (PCR) to identify causative pathogens in children with suspected systemic bacterial or fungal infection.

methodsProspective observational study in 39 children with systemic inflammatory response syndrome (SIRS) under empiric antibiotic treatment. Primary outcome was the rate of positive blood cultures (BC), compared to the rate of positive SeptiFast (SF) results.

resultsIn total, 14 SF-samples yielded positive results, compared to 4 positive BC (p < 0.05). All blood cultures and 13 of 14 positive SF-tests were considered infection. Median time for positive BC was 2 days, and time to definite result was 6 days, compared to 12 h for SF. Antimicrobial therapy was adapted in 7 of the 14 patients with positive SeptiFast, and in 3 of the 4 patients with positive BC. Best predictive power for positive SF shown by receiver-operating characteristic was demonstrated for procalcitonin PCT (Area under the curve AUC: 0.79), compared to C-reactive protein CRP (AUC: 0.51) and leukocyte count (AUC: 0.46). A procalcitonin threshold of 0.89 ng/ml yielded a sensitivity of 0.82 and a specifity of 0.7. Children with a positive SeptiFast result on day 0 had a significantly higher risk to require treatment on the Pediatric Intensive Care Unit or to be deceased on day 30 (Odds-Ratio 8.62 (CI 1.44-51.72).

conclusionsThe additional testing with SeptiFast in antimicrobially pre-treated children with systemic inflammation enhances the rate of pathogen detection. The influence of multiplex PCR on clinically relevant outcome parameters has to be further evaluated. (

trial registrationDRKS00004694).

Indexed as

AdolescentAnti-Bacterial AgentsArea Under CurveAspergillus fumigatusBacteremiaCalcitoninCandidaChildChild, PreschoolC-Reactive ProteinEnterococcusEscherichia coliFemaleFungemiaHumansInfantAnti-Bacterial AgentsCalcitoninC-Reactive ProteinAntimicrobial treatmentBlood cultureChildrenSeptiFastSystemic Inflammatory Response Syndrome (SIRS)

Identifiers

PMID27503068
PMCPMC4977629
OpenAlexW2509351565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.